Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175) : a systematic review and economic evaluation

5 days ago
bookmarkBookmark

Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175) : a systematic review and economic evaluation is a book. It was written by Janette Greenhalgh and published by NIHR Journals Library in 2015.

Key facts

plus See more facts

Extract data

Download datasets about Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175) : a systematic review and economic evaluation:

dataset Dataset of books series that contain Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175) : a systematic review and economic evaluation:

dataset Dataset of book subjects that contain Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175) : a systematic review and economic evaluation:

"Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175) : a systematic review and economic evaluation" is one of the books by Janette Greenhalgh, books by NIHR Journals Library and 2,617,384 books in our database.

Related

Connected or similar to Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175) : a systematic review and economic evaluation: .

This dashboard is based on data from: The British Library.

This content is available under the CC BY 4.0 license.